Development and validation of a prognostic prediction model for alpha-fetoprotein-negative hepatocellular carcinoma with microvascular invasion after surgery

doi:10.3748/wjg.123092

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 33, Issue 2

This Article

(2)

(0)

(89)

Peer-Review Report of This Article

Supplementary Materials of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Jan 14, 2027; 33(2): 123092
Published online Jan 14, 2027. doi: 10.3748/wjg.123092

Full Size Figure Download Figure

Figure 1 The flowchart of hepatocellular carcinoma patient enrollment. HCC: Hepatocellular carcinoma; CCC: Cholangiocarcinoma.

Citation: Liao MJ, Zhou Y, Wang ZL, Wang XX, Ai X, Song LN, Fei R, Cong X, Liu F, Zhu PP, Chen HS, Liao WJ, Rao HY. Development and validation of a prognostic prediction model for alpha-fetoprotein-negative hepatocellular carcinoma with microvascular invasion after surgery. World J Gastroenterol 2027; 33(2): 123092
URL: https://www.wjgnet.com/1007-9327/full/v33/i2/123092.htm
DOI: https://dx.doi.org/10.3748/wjg.123092

Liao MJ, Zhou Y, Wang ZL, Wang XX, Ai X, Song LN, Fei R, Cong X, Liu F, Zhu PP, Chen HS, Liao WJ, Rao HY. Development and validation of a prognostic prediction model for alpha-fetoprotein-negative hepatocellular carcinoma with microvascular invasion after surgery. World J Gastroenterol 2027; 33(2): 123092 [DOI: 10.3748/wjg.123092]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.